TRV GP IV, LLC's Form 4 filing
Tango Therapeutics, Inc. (TNGX) · filed Oct 27, 2025
- Accession no.
- 0001193125-25-251606
- Filed
- Oct 27, 2025, 4:15 PM ET
- Trade date
- Oct 23, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $4.85M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| TRV GP IV, LLCCIK 0001688325 | 10% Owner |
| Third Rock Ventures GP IV, L.P.CIK 0001688326 | 10% Owner |
| Third Rock Ventures IV, L.P.CIK 0001688327 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 23, 2025 | Common Stock | SSaleDisposed | −477,401 | $10.15F1 | −$4,846,574.95 | 13,386,574 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
Referenced by the price of 1 transaction in Table I.